Skip to content

MDCXW MEDICUS PHARMA LTD

Follow

*W EXP 11/15/202 (warrant or right), issuer CIK 1997296

Filings received so far for Q3 2026: 7 13F filers report a position in MDCXW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Private Advisor Group, LLC43,500$13.1K<0.01%new13F-HRTimeline
Anson Funds Management LPin group Anson Funds Management LP42,400$12.7K<0.01%013F-HRTimelineGroup
Corient Private Wealth LPin group Corient Private Wealth LP15,000$4.5K<0.01%new13F-HRTimelineGroup
Connective Capital Management, LLC6,000$1.8K<0.01%013F-HRTimeline
UBS Group AGin group UBS Group AG1,780$534<0.01%-42313F-HRTimelineGroup
ARMISTICE CAPITAL, LLCin group ARMISTICE CAPITAL, LLC60,600$364<0.01%013F-HRTimelineGroup
Clear Street Group Inc.in group Clear Street Group Inc.89$27<0.01%new13F-HRTimelineGroup